American International Group’s Aratana Therapeutics, Inc. PETX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-30,759
Closed -$159K 3116
2019
Q2
$159K Buy
30,759
+1,201
+4% +$5.4K ﹤0.01% 2386
2019
Q1
$106K Sell
29,558
-958
-3% -$4.15K ﹤0.01% 2589
2018
Q4
$187K Buy
30,516
+367
+1% +$2.24K ﹤0.01% 2220
2018
Q3
$176K Buy
30,149
+1,057
+4% +$5.28K ﹤0.01% 2514
2018
Q2
$124K Buy
29,092
+2,630
+10% +$13.3K ﹤0.01% 2666
2018
Q1
$117K Sell
26,462
-1,423
-5% -$6.35K ﹤0.01% 2580
2017
Q4
$147K Buy
27,885
+730
+3% +$4.47K ﹤0.01% 2513
2017
Q3
$166K Buy
27,155
+2,031
+8% +$12.9K ﹤0.01% 2389
2017
Q2
$182K Buy
25,124
+4,590
+22% +$28.2K ﹤0.01% 2330
2017
Q1
$109K Buy
20,534
+1,354
+7% +$9.14K ﹤0.01% 2547
2016
Q4
$138K Sell
19,180
-50
-0.3% -$404 ﹤0.01% 2412
2016
Q3
$180K Buy
19,230
+29
+0.2% +$241 ﹤0.01% 2241
2016
Q2
$121K Buy
19,201
+1,841
+11% +$11.8K ﹤0.01% 2462
2016
Q1
$96K Hold
17,360
﹤0.01% 3458
2015
Q4
$97K Sell
17,360
-30
-0.2% -$198 ﹤0.01% 3509
2015
Q3
$147K Buy
17,390
+20
+0.1% +$338 ﹤0.01% 3105
2015
Q2
$263K Sell
17,370
-689
-4% -$9.95K ﹤0.01% 2756
2015
Q1
$289K Hold
18,059
﹤0.01% 2636
2014
Q4
$322K Buy
18,059
+2,091
+13% +$26.1K ﹤0.01% 2526
2014
Q3
$160K Sell
15,968
-12
-0.1% -$145 ﹤0.01% 3156
2014
Q2
$249K Buy
15,980
+11,484
+255% +$163K ﹤0.01% 2795
2014
Q1
$83.4K Buy
4,496
+108
+2% +$2.16K ﹤0.01% 3562
2013
Q4
$83.8K Buy
+4,388
New +$89.1K ﹤0.01% 3473

Other funds holding PETX

American International Group's PETX Position: Q3 2019 in Review

American International Group sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 30,759 shares — an estimated $159K sold.

American International Group first reported a position in PETX in Q4 2013 and held it in 23 quarters. The position peaked at $322K in Q4 2014. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

  • American International Group reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • American International Group sold 30,759 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $159K.
  • American International Group first reported a position in Aratana Therapeutics, Inc. in Q4 2013 and held it in 23 quarters.
  • American International Group's Aratana Therapeutics, Inc. position peaked at $322K in Q4 2014.
  • 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on American International Group's 13F filing for Q3 2019, filed 8 Nov 2019.